Comparison of antibiograms developed for inpatients and primary care outpatients

Diagnostic Microbiology and Infectious Disease

Volumn 76, Issue 1, 2013, Pages 73-79

  McGregor, Jessina C ^a   Bearden, David T ^a   Townes, John M ^b   Sharp, Susan E ^c   Gorman, Paul N ^b   Elman, Miriam R ^a   Mori, Motomi ^b   Smith, David H ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Regional Laboratory   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

Ambulatory; Antimicrobial stewardship; Bacterial resistance; Infectious disease; Pharmacy practice

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; METICILLIN; NITROFURANTOIN; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; ENTEROCOCCUS; ESCHERICHIA COLI; HEALTH CARE SYSTEM; HEALTH MAINTENANCE ORGANIZATION; HOSPITAL PATIENT; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; NONHUMAN; OUTPATIENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; INPATIENTS; KLEBSIELLA PNEUMONIAE; MALE; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OUTPATIENTS; PRIMARY HEALTH CARE; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 84876728684     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.01.026     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention; National Center for Immunization and Respiratory Diseases; Division of Bacterial Diseases (2012). Get smart: know when antibiotics work. Retrieved April 5, 2012, from . http://www.cdc.gov/getsmart.
2. Gonzales R., Malone D.C., Maselli J.H., Sande M.A. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001, 33(6):757-762.
3. Gonzales R., Steiner J.F., Lum A., Barrett P.H. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999, 281(16):1512-1519.
4. Gupta K., Hooton T.M., Naber K.G., Wullt B., Colgan R., Miller L.G., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011, 52(5):e103-e120.
5. Hicks L.A., Chien Y.W., Taylor T.H., Haber M., Klugman K.P. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. Clin Infect Dis 2011, 53(7):631-639.
6. Hindler J.F., Barton M., Callihan D.R., Erdman S.M., Evangelista A.T., Jenkins S.G., et al. Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline-third edition (M39-A3) 2009, Clinical and Laboratory Standards Institute, Wayne, PA, 26.
7. Hooton T.M., Besser R., Foxman B., Fritsche T.R., Nicolle L.E. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 2004, 39(1):75-80.
8. Huttner B., Samore M. Outpatient antibiotic use in the United States: time to "get smarter". Clin Infect Dis 2011, 53(7):640-643.
9. Jones M.E., Karlowsky J.A., Draghi D.C., Thornsberry C., Sahm D.F., Nathwani D. Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. Int J Antimicrob Agents 2003, 22(4):406-419.
10. Karlowsky J.A., Kelly L.J., Thornsberry C., Jones M.E., Sahm D.F. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 2002, 46(8):2540-2545.
11. Lagace-Wiens P.R., Simner P.J., Forward K.R., Tailor F., Adam H.J., Decorby M., et al. Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada-results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 2011, 69(3):314-319.
12. MacDougall C., Polk R.E. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev 2005, 18(4):638-656. PMC1265911.
13. McCaig L.F., Besser R.E., Hughes J.M. Antimicrobial drug prescription in ambulatory care settings, United States, 1992-2000. Emerg Infect Dis 2003, 9(4):432-437.
14. McGregor J.C., Dumyati G., Casiano-Colon A.E., Chang P.J., Klevens R.M. Usefulness of antibiogram surveillance for methicillin-resistant Staphylococcus aureus in outpatient pediatric populations. Diagn Microbiol Infect Dis 2009, 64(1):78-83.
15. Mera R.M., Miller L.A., Amrine-Madsen H., Sahm D.F. The impact of the pneumococcal conjugate vaccine on antimicrobial resistance in the United States since 1996: evidence for a significant rebound by 2007 in many classes of antibiotics. Microb Drug Resist 2009, 15(4):261-268.
16. Mera R.M., Suaya J.A., Amrine-Madsen H., Hogea C.S., Miller L.A., Lu E.P., et al. Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion. Microb Drug Resist 2011, 17(2):321-328.
17. Metlay J.P., Shea J.A., Asch D.A. Antibiotic prescribing decisions of generalists and infectious disease specialists: thresholds for adopting new drug therapies. Med Decis Making 2002, 22(6):498-505.
18. Owens R.C. Antimicrobial stewardship: concepts and strategies in the 21st century. Diagn Microbiol Infect Dis 2008, 61(1):110-128.
19. Shapiro D.J., Gonzales R., Cabana M.D., Hersh A.L. National trends in visit rates and antibiotic prescribing for children with acute sinusitis. Pediatrics 2011, 127(1):28-34. PMC3010093.
20. Sharp S.E., Robinson A., Saubolle M., Carroll S.C.M.K., Baselski V. Cumitech 7B, Lower respiratory tract infections 2004, S. E. Sharp, Washington, DC.
21. Steinman M.A., Gonzales R., Linder J.A., Landefeld C.S. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med 2003, 138(7):525-533.
22. Tillotson G.S., Draghi D.C., Sahm D.F., Tomfohrde K.M., Del Fabro T., Critchley I.A. Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study. J Antimicrob Chemother 2008, 62(1):109-115.
23. Xu R., Polk R.E., Stencel L., Lowe D.K., Guharoy R., Duggal R.W., et al. Antibiogram compliance in University HealthSystem Consortium participating hospitals with Clinical and Laboratory Standards Institute guidelines. Am J Health Syst Pharm 2012, 69(7):598-606.
24. Yawn B.P., Wollan P., Cockerill F., Lydick E. Antibiotic bacterial resistance in ambulatory patients. Minn Med 2000, 83(10):53-58.
25. Zapantis A., Lacy M.K., Horvat R.T., Grauer D., Barnes B.J., O'Neal B., et al. Nationwide antibiogram analysis using NCCLS M39-A guidelines. J Clin Microbiol 2005, 43(6):2629-2634.